Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wielenga

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Digestive Diseases and Sciences|October 2, 2002
Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombastheniaHenk R van Buuren, Jenne J Wielenga
Anti-Cancer Drugs|May 1, 1993
Granulocyte-macrophage colony stimulating factor (GM-CSF) in the treatment of hematological malignanciesB Löwenberg, G E de Greef, J J Wielenga
The Canadian Journal of Hospital Pharmacy|December 1, 1993
Management considerations to implementing pharmaceutical careK Wichman, B Hales, M O'Brodovich, et al.
Leukemia|January 1, 1996
Recombinant human interleukin-3 (rH IL-3) in combination with remission induction chemotherapy in patients with relapsed acute myelogenous leukemia (AML): a phase I/II studyJ J Wielenga, E Vellenga, A Groenewegen, et al.
Progress in Clinical and Biological Research|January 1, 1990
Factors influencing reconstitution by bone marrow transplantationD W van Bekkum, J J Wielenga, F van Gils, et al.
The Histochemical Journal|June 1, 1997
p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesisJ W Mulder, V J Wielenga, S T Pals, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 2, 1995
[A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin]M H Silbermann, I C Gyssens, J J Wielenga, et al.
The Netherlands Journal of Medicine|January 12, 1999
Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and BelgiumE P Mauser-Bunschoten, A de Goede-Bolder, J J Wielenga, et al.
Leukemia|September 1, 1995
Conditions for engraftment of human acute myeloid leukemia (AML) in SCID miceW Terpstra, A Prins, T Visser, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Interleukin-3G Wagemaker, H Burger, F C van Gils, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Digestive Diseases and Sciences|October 2, 2002
Successful surgery using recombinant factor VIIa for recurrent, idiopathic nonulcer duodenal bleeding in a patient with Glanzmann's thrombastheniaHenk R van Buuren, Jenne J Wielenga
Anti-Cancer Drugs|May 1, 1993
Granulocyte-macrophage colony stimulating factor (GM-CSF) in the treatment of hematological malignanciesB Löwenberg, G E de Greef, J J Wielenga
The Canadian Journal of Hospital Pharmacy|December 1, 1993
Management considerations to implementing pharmaceutical careK Wichman, B Hales, M O'Brodovich, et al.
Leukemia|January 1, 1996
Recombinant human interleukin-3 (rH IL-3) in combination with remission induction chemotherapy in patients with relapsed acute myelogenous leukemia (AML): a phase I/II studyJ J Wielenga, E Vellenga, A Groenewegen, et al.
Progress in Clinical and Biological Research|January 1, 1990
Factors influencing reconstitution by bone marrow transplantationD W van Bekkum, J J Wielenga, F van Gils, et al.
The Histochemical Journal|June 1, 1997
p53 and CD44 as clinical markers of tumour progression in colorectal carcinogenesisJ W Mulder, V J Wielenga, S T Pals, et al.
Nederlands Tijdschrift Voor Geneeskunde|December 2, 1995
[A patient with acute leukemia and meningitis caused by Staphylococcus epidermidis treated with fosfomycin]M H Silbermann, I C Gyssens, J J Wielenga, et al.
The Netherlands Journal of Medicine|January 12, 1999
Continuous infusion of recombinant factor VIIa in patients with haemophilia and inhibitors. Experience in The Netherlands and BelgiumE P Mauser-Bunschoten, A de Goede-Bolder, J J Wielenga, et al.
Leukemia|September 1, 1995
Conditions for engraftment of human acute myeloid leukemia (AML) in SCID miceW Terpstra, A Prins, T Visser, et al.
Biotherapy (Dordrecht, Netherlands)|January 1, 1990
Interleukin-3G Wagemaker, H Burger, F C van Gils, et al.
Pageof 4